Skip to main content
Clinical Trials/ACTRN12618000303246
ACTRN12618000303246
Recruiting
Phase 4

Randomised controlled trial of paracetamol or ibuprofen, as required for fever and pain in the first year of life, for prevention of asthma at age six years: Paracetamol or Ibuprofen in the Primary Prevention of Asthma in Tamariki (PIPPA Tamariki).

Auckland District Health Board0 sites3,922 target enrollmentFebruary 28, 2018

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Auckland District Health Board
Enrollment
3922
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 28, 2018
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Birth within Auckland and Wellington regions.
  • 2\. Age \<8 weeks (chronological age).

Exclusion Criteria

  • Infants will not be enrolled if ANY of the following apply:
  • 1\. Parent is unable to give informed consent for participation in the trial;
  • 2\. Highly unlikely to remain in New Zealand for the first 6 years of life;
  • 3\. Chronic disease associated with limited life expectancy (i.e., less than 6 years);
  • 4\. Gestational age at birth \<32 weeks;
  • 5\. Previous exposure to paracetamol or ibuprofen since birth.

Outcomes

Primary Outcomes

Not specified

Similar Trials